Demand for outsourcing microbial manufacturing has increased dramatically in recent years and will doubtlessly continue as novel drugs are more rapidly discovered. Due to our long history in drug development, we understand the significance of choosing the right microbial CDMO and the long-term impact on companies that choose incorrectly. In the face of an ever-growing […]
Key Considerations for Choosing the Right Microbial CDMO Partner Read More »
Chinese Hamster Ovary (CHO) cells are considered the gold standard in the production of biologics. Shown here at 100x. Biologics acting as targeted therapies have changed the foundations of modern medicine and given immense hope to patients suffering from previously considered untreatable diseases. As biological drug substance development evolves and technology becomes more and more
Antibody reduction is the spontaneous degradation of inter-chain disulfide bonds resulting in a build-up of partial related substances of an IgG in bioprocess streams. Join Aaron Martin, Associate Director of Analytical Development, for the live webinar on Tuesday, May 23, 2023 | 12pm EDT (US) | 11am CT (US).
Antibody Reduction in Bioprocessing
X-talk Read More »
Any current Good Manufacturing Practice (cGMP) E.coli program must be based on a solid strain development strategy. This thought led to the development of Cytovance’s Keystone Expression System to provide a robust, high-yield E.coli strain to support cGMP manufacturing of a biologic.
The number and variety of protein therapeutics have increased dramatically in recent years. To satisfy therapeutic demand, these molecules must be produced at large scale in mammalian or bacterial cell hosts; but with the greater variety in protein therapeutic molecules
Process Characterization & Statistical Modeling — Transforming Data into Knowledge Throughout the Product Lifecycle, Upcoming Webinar Hosted by Xtalks. It’s no surprise that data plays a pivotal role in the biopharmaceutical industry.
Oklahoma City, OK. – October 18, 2019 – Cytovance® Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today the company will participate in the upcoming Recent Advances in Fermentation Technology (#RAFT) Conference to be held October 29 – November 1, 2017 at the Hyatt Coconut Point, Bonita Springs (Ft. Myers), Florida.
